Nuvalent (NUVL) EBITDA (2020 - 2026)

Nuvalent (NUVL) has 7 years of EBITDA data on file, last reported at -$119.4 million in Q1 2026.

• Quarterly EBITDA fell 25.94% year-over-year to -$119.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$438.9 million (down 36.05% YoY) and the FY2025 annual result came in at -$414.3 million, down 47.77% from the prior year.
• EBITDA slipped to -$119.4 million in Q1 2026, from -$102.2 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$17.7 million in Q1 2022 to a low of -$119.4 million in Q1 2026.
• A 5-year average of -$61.7 million and a median of -$52.6 million in 2024 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA sank 187.05% — and 2025, when it fell 18.46%.
• Tracing NUVL's EBITDA over 5 years: stood at -$29.3 million in 2022, then plunged by 58.49% to -$46.4 million in 2023, then plunged by 85.84% to -$86.3 million in 2024, then fell by 18.46% to -$102.2 million in 2025, then decreased by 16.8% to -$119.4 million in 2026.
• The last three EBITDA figures came in at -$119.4 million (Q1 2026), -$102.2 million (Q4 2025), and -$112.7 million (Q3 2025), per Business Quant data.